Star Therapeutics
Star Therapeutics raises $125M Series D
Quick Facts
Star Therapeutics: Series D Funding Round
Star Therapeutics has successfully raised $125M in Series D funding.
Company Overview
Developing antibody therapies for autoimmune and inflammatory diseases
Funding Details
The Series D round was led by Sanofi Ventures, with participation from Viking Global Investors.
Company Information
- Headquarters: South San Francisco, CA
- Founded: 2016
- Employees: 180+
- Category: HealthTech
Investment
Star Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Sanofi Ventures: Verified investor in Series D
- Viking Global Investors: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
